Impact of preformulation on drug development. - Wikidata - awgldk - TriplyDB

Impact of preformulation on drug development.

Impact of preformulation on drug development.

http://www.wikidata.org/entity/Q38093663

about

Characterization and Trypanocidal Activity of a Novel Pyranaphthoquinone.Franz Diffusion Cell Approach for Pre-Formulation Characterisation of Ketoprofen Semi-Solid Dosage Forms

P2860

Q48250989-0A2529D5-D721-4AA3-9004-3B1ADAB4C206 Q58762561-1D211367-04B4-4C6F-9DF6-5CE256CD3AAA

P2860

Impact of preformulation on drug development.

http://www.wikidata.org/entity/Q38093663

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Impact of preformulation on drug development.

@en

type

label

Impact of preformulation on drug development.

@en

prefLabel

Impact of preformulation on drug development.

@en

P1433

Q38093663-2D48D7D5-9979-4F03-97BE-CB2EDE87D414

P1476

Q38093663-FF46040F-E4DE-4781-80C2-7B4DC2ADB253

P2093

Q38093663-C5A15160-0146-463F-8167-3DB6443E4C0A

P2860

Q38093663-031B3C26-45E2-41AD-B628-829AF7BE24F0

Q38093663-09BA4C09-B09F-40C9-8A14-153355B7FA04

Q38093663-09D5185B-1077-436A-9CAB-D8DC89DDA907

Q38093663-0C661904-1E3F-47D5-906E-CFE0544A7E83

Q38093663-0D21DB59-2CD0-40C7-B2C9-B7720709BCB3

Q38093663-10BFCADF-81BD-49B6-BE38-ADFF2DBAEAE3

Q38093663-11E4D8F1-DAF0-4FFA-8219-0110CDA8D467

Q38093663-16530058-56DB-4D65-A43E-925792915113

Q38093663-1911F142-1E6D-4F40-AA6B-37E523D0B130

Q38093663-1CF5A5E5-7E6F-4AD5-8F92-90FF33A9E464

P304

Q38093663-67E76784-75E0-4BB1-A2B2-9FDD81BED4D0

P31

Q38093663-5A035F09-E9FF-49A3-91F0-5F5DA3D58532

P356

Q38093663-C0470C04-A642-4ABC-A719-AFDEE3AFB243

P407

Q38093663-A3A87648-70DD-4EEB-8946-3875772E446C

P433

Q38093663-BC2ECFA2-D67D-48FD-845F-B2BC59A21D29

P478

Q38093663-222A7AAE-22CA-4401-92D4-94A622FF901B

P50

Q38093663-D979761F-DD58-409C-AAA3-7D7B383EA3A5

P577

Q38093663-5A0AC058-60FD-44E5-B671-24945DEA107F

P5875

Q38093663-A3E36A66-D3DC-4870-837E-D561F925D84B

P698

Q38093663-71A5DCA4-4750-4EA8-B572-F33DE055353A

P356

17425247.2013.783563

P1433

Expert Opinion on Drug Delivery

P1476

Impact of preformulation on drug development.

@en

P2093

Ram A Vishwakarma

http://www.w3.org/2001/XMLSchema#string

P2860

ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

Predicting skin permeability

Prediction of intestinal absorption: comparative assessment of GASTROPLUS and IDEA.

Drug-like properties and the causes of poor solubility and poor permeability.

The use of pharmacokinetic and pharmacodynamic data in the assessment of drug safety in early drug development

Prediction of aqueous solubility of a diverse set of compounds using quantitative structure-property relationships.

Novel identification of pseudopolymorphic changes of theophylline during wet granulation using near infrared spectroscopy.

The basics of preclinical drug development for neurodegenerative disease indications.

Biopharmaceutics and pharmacokinetics in drug research.

P304

1239-1257

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/17425247.2013.783563

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Sonali S Bharate

P577

2013-03-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236086181

http://www.w3.org/2001/XMLSchema#string

P698

23534681

http://www.w3.org/2001/XMLSchema#string